Yi Jin PhD

Yi Jin has more than 20 years of academic research and enterprise research and development experience, including the University of California, Berkeley, Bayer, Kingsley, and other internationally renowned institutes, large pharmaceutical companies, and CROs. She focuses on tumor immunity, autoimmune, single-gene genetic diseases, etc., and has rich early research and preclinical development experience, including promoting technology platform construction.

In terms of academic research, there are Dozens of academic papers in academic research in journals such as Cell, Molecular Cell, Development Cell, J. Cell Biol., J. Cell. BioChem. She has rich team management capabilities, including multi-disciplinary and cross-professional team management, especially early R & D, transformation of medicine, and preclinical pharmacy, such as CMC, QA/QC, etc. Bachelor of Sichuan University, Ph.D. of Iowa State University, Postdoctoral University of California, Berkeley.